Authors:
HELLMARK T
NILES JL
COLLINS AB
MCCLUSKEY RT
BRUNMARK C
Citation: T. Hellmark et al., COMPARISON OF ANTI-GBM ANTIBODIES IN SERA WITH OR WITHOUT ANCA, Journal of the American Society of Nephrology, 8(3), 1997, pp. 376-385
Citation: T. Hellmark et al., ANTI-GBM ANTIBODIES IN GOODPASTURE-SYNDROME - ANATOMY OF AN EPITOPE, Nephrology, dialysis, transplantation, 12(4), 1997, pp. 646-648
Authors:
GARWICZ D
LINDMARK A
HELLMARK T
GLADH M
JOGI J
GULLBERG U
Citation: D. Garwicz et al., CHARACTERIZATION OF THE PROCESSING AND GRANULAR TARGETING OF HUMAN PROTEINASE-3 AFTER TRANSFECTION TO THE RAT RBL OR THE MURINE 32D LEUKEMIC-CELL LINES, Journal of leukocyte biology, 61(1), 1997, pp. 113-123
Authors:
SEGELMARK M
PERSSON B
HELLMARK T
WIESLANDER J
Citation: M. Segelmark et al., BINDING AND INHIBITION OF MYELOPEROXIDASE (MPO) - A MAJOR FUNCTION OFCERULOPLASMIN, Clinical and experimental immunology, 108(1), 1997, pp. 167-174
Authors:
HELLMARK T
BRUNMARK C
TROJNAR J
WIESLANDER J
Citation: T. Hellmark et al., EPITOPE SPECIFICITY OF ANTI-GBM ANTIBODIES DEMONSTRATED WITH SYNTHETIC PEPTIDES, Kidney international, 49(3), 1996, pp. 927-927
Authors:
HELLMARK T
BRUNMARK C
TROJNAR J
WIESLANDER J
Citation: T. Hellmark et al., EPITOPE MAPPING OF ANTIGLOMERULAR BASEMENT-MEMBRANE (GBM) ANTIBODIES WITH SYNTHETIC PEPTIDES, Clinical and experimental immunology, 105(3), 1996, pp. 504-510
Authors:
HELLMARK T
BRUNMARK C
TROJNAR J
WIESLANDER J
Citation: T. Hellmark et al., EPITOPE SPECIFICITY OF ANTI-GBM ANTIBODIES DEMONSTRATED WITH SYNTHETIC PEPTIDES, Journal of the American Society of Nephrology, 6(3), 1995, pp. 832-832
Authors:
SEGELMARK M
PERSSON B
HELLMARK T
WIESLANDER J
Citation: M. Segelmark et al., INTERACTIONS BETWEEN THE ANCA-ANTIGEN MYELO-PEROXIDASE (MPO) AND THE COMPLEMENT COMPONENT C3DG AND CERULOPLASMIN, Journal of the American Society of Nephrology, 6(3), 1995, pp. 853-853
Citation: T. Hellmark et al., CHARACTERIZATION OF ANTI-GBM ANTIBODIES INVOLVED IN GOODPASTURES-SYNDROME, Kidney international, 46(3), 1994, pp. 823-829